Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver D Howes

Showing results (311-320 of 329) with videos related to

Pageof 33
Sort By:
The Lancet. Psychiatry|April 3, 2025
INTEGRATE: international guidelines for the algorithmic treatment of schizophreniaRobert A McCutcheon, Toby Pillinger, Ioana Varvari, et al.
Wellcome Open Research|April 18, 2024
Trace amine-associated receptor 1 (TAAR1) agonists for psychosis: protocol for a living systematic review and meta-analysis of human and non-human studiesSpyridon Siafis, Robert McCutcheon, Virginia Chiocchia, et al.
Brain : a Journal of Neurology|December 1, 2025
Immune alterations in schizophrenia and the effects of a therapeutic antibody: a neuroimaging studyYuya Mizuno, Ines Carreira Figueiredo, Toby Pillinger, et al.
F1000Research|January 23, 2025
Muscarinic receptor agonists and positive allosteric modulators in animal models of psychosis: protocol for a systematic review and meta-analysisSpyridon Siafis, Nobuyuki Nomura, Johannes Schneider-Thoma, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 3, 2020
The role of dopamine dysregulation and evidence for the transdiagnostic nature of elevated dopamine synthesis in psychosis: a positron emission tomography (PET) study comparing schizophrenia, delusional disorder, and other psychotic disordersPak Wing Calvin Cheng, Wing Chung Chang, Gladys G Lo, et al.
Journal of Psychopharmacology (Oxford, England)|December 13, 2019
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for PsychopharmacologyThomas Re Barnes, Richard Drake, Carol Paton, et al.
Medrxiv : the Preprint Server for Health Sciences|December 11, 2023
Dopaminergic-related Anatomical Pattern of Dorsal Striatum in SchizophreniaChao Xie, Shitong Xiang, Yueyuan Zheng, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2023
Dopamine and schizophrenia from bench to bedside: Discovery of a striatal co-expression risk gene set that predicts in vivo measures of striatal functionLeonardo Sportelli, Daniel P Eisenberg, Roberta Passiatore, et al.
Nature Communications|April 30, 2024
Dopamine signaling enriched striatal gene set predicts striatal dopamine synthesis and physiological activity in vivoLeonardo Sportelli, Daniel P Eisenberg, Roberta Passiatore, et al.
The Lancet. Psychiatry|December 3, 2023
Relapse in clinically stable adult patients with schizophrenia or schizoaffective disorder: evidence-based criteria derived by equipercentile linking and diagnostic test accuracy meta-analysisSpyridon Siafis, Lasse Brandt, Robert A McCutcheon, et al.
Pageof 33

Showing results (311-320 of 329) with videos related to

Sort By:
Pageof 33
The Lancet. Psychiatry|April 3, 2025
INTEGRATE: international guidelines for the algorithmic treatment of schizophreniaRobert A McCutcheon, Toby Pillinger, Ioana Varvari, et al.
Wellcome Open Research|April 18, 2024
Trace amine-associated receptor 1 (TAAR1) agonists for psychosis: protocol for a living systematic review and meta-analysis of human and non-human studiesSpyridon Siafis, Robert McCutcheon, Virginia Chiocchia, et al.
Brain : a Journal of Neurology|December 1, 2025
Immune alterations in schizophrenia and the effects of a therapeutic antibody: a neuroimaging studyYuya Mizuno, Ines Carreira Figueiredo, Toby Pillinger, et al.
F1000Research|January 23, 2025
Muscarinic receptor agonists and positive allosteric modulators in animal models of psychosis: protocol for a systematic review and meta-analysisSpyridon Siafis, Nobuyuki Nomura, Johannes Schneider-Thoma, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 3, 2020
The role of dopamine dysregulation and evidence for the transdiagnostic nature of elevated dopamine synthesis in psychosis: a positron emission tomography (PET) study comparing schizophrenia, delusional disorder, and other psychotic disordersPak Wing Calvin Cheng, Wing Chung Chang, Gladys G Lo, et al.
Journal of Psychopharmacology (Oxford, England)|December 13, 2019
Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for PsychopharmacologyThomas Re Barnes, Richard Drake, Carol Paton, et al.
Medrxiv : the Preprint Server for Health Sciences|December 11, 2023
Dopaminergic-related Anatomical Pattern of Dorsal Striatum in SchizophreniaChao Xie, Shitong Xiang, Yueyuan Zheng, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2023
Dopamine and schizophrenia from bench to bedside: Discovery of a striatal co-expression risk gene set that predicts in vivo measures of striatal functionLeonardo Sportelli, Daniel P Eisenberg, Roberta Passiatore, et al.
Nature Communications|April 30, 2024
Dopamine signaling enriched striatal gene set predicts striatal dopamine synthesis and physiological activity in vivoLeonardo Sportelli, Daniel P Eisenberg, Roberta Passiatore, et al.
The Lancet. Psychiatry|December 3, 2023
Relapse in clinically stable adult patients with schizophrenia or schizoaffective disorder: evidence-based criteria derived by equipercentile linking and diagnostic test accuracy meta-analysisSpyridon Siafis, Lasse Brandt, Robert A McCutcheon, et al.
Pageof 33